From: STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
Variables | STK25 expression | χ2 | P | |
---|---|---|---|---|
Low (n = 290) (%) | High (n = 75) (%) | |||
Gender | 5.217 | 0.022 | ||
Male | 188 (64.8) | 59 (78.7) | ||
Female | 102 (35.2) | 16 (21.3) | ||
Age | 1.354 | 0.245 | ||
≦65 | 176 (60.7) | 51 (68.0) | ||
> 65 | 114 (39.3) | 24 (32.0) | ||
Child–Pugh grade | 3.909 | 0.142 | ||
A | 179 (61.7) | 37 (49.3) | ||
B–C | 17 (5.9) | 5 (6.7) | ||
Unknow | 94 (32.4) | 33 (44.0) | ||
TNM stage | 10.618 | 0.030 | ||
I | 139 (47.9) | 31 (41.3) | ||
II | 70 (24.1) | 14 (18.7) | ||
III | 56 (19.3) | 27 (36.0) | ||
IV | 4 (1.4) | 0 (0.0) | ||
Unknow | 21 (7.3) | 3 (4.0) | ||
Histologic grade | 3.217 | 0.200 | ||
G1–G2 | 177 (61.0) | 53 (70.6) | ||
G3–G4 | 108 (37.2) | 22 (29.4) | ||
Unknow | 5 (1.8) | 0 (0.0) | ||
Vascular invasion | 9.660 | 0.008 | ||
No | 172 (59.3) | 33 (44.0) | ||
Yes | 83 (28.6) | 23 (30.7) | ||
Unknow | 35 (12.1) | 19 (25.3) | ||
Ishak score | 2.884 | 0.236 | ||
0–4 | 111 (38.3) | 21 (28.0) | ||
5–6 | 58 (20.0) | 19 (25.3) | ||
Unknow | 121 (41.7) | 35 (46.7) |